Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
Pathology. 2020 Aug;52(5):507-514. doi: 10.1016/j.pathol.2020.06.002. Epub 2020 Jun 16.
Foci of necrosis are frequently seen in malignant tumours and may be due to a variety of causes. Different types of necrosis are given various names based upon their morphological features and presumed pathogenesis, such as coagulative, liquefactive and fibrinoid necrosis. Here, we propose the term 'granular necrosis' (GN) for a specific form of tumour necrosis characterised by the presence of well-defined necrotic foci being sharply demarcated from adjacent viable tumour. A constant feature is loss of architecture resulting in an amorphous necrotic mass containing granular nuclear and cytoplasmic debris, without an associated neutrophilic infiltrate. There is usually extensive karyorrhexis, which in larger tumours is more prominent at the periphery. These foci are often microscopic but may range up to several millimetres or larger in size. This distinctive form of necrosis has been erroneously given a variety of names in the literature including coagulative necrosis and microscopic necrosis, which on the basis of the aforementioned gross and microscopic findings is inappropriate. It is apparent that this is a specific form of necrosis, hence the descriptive term 'granular necrosis' that differentiates this form of necrosis from other types. The presence of GN is recognised as occurring in a variety of tumour types, being commonly seen in renal cell carcinoma, where it has been shown to have independent prognostic significance. In some epithelial and stromal tumours of the uterus, the presence of GN also has prognostic significance and is a defining feature for the differentiation of uterine leiomyoma and leiomyosarcoma. The pathogenesis of GN is unresolved. It does not show the features of apoptosis and in recent studies has been shown to have some of the molecular changes associated with necroptosis.
坏死灶在恶性肿瘤中经常可见,可能由多种原因引起。不同类型的坏死根据其形态特征和推测的发病机制有不同的名称,如凝固性、液化性和纤维蛋白样坏死。在这里,我们提出了“颗粒状坏死”(GN)这个术语,用于描述一种特定形式的肿瘤坏死,其特征是存在界限分明的明确坏死灶,与相邻的存活肿瘤截然分开。一个恒定的特征是失去结构,导致无定形的坏死物质,其中含有颗粒状的核和细胞质碎片,没有相关的中性粒细胞浸润。通常有广泛的核碎裂,在较大的肿瘤中,边缘更为明显。这些坏死灶通常是显微镜下的,但也可能达到数毫米或更大的大小。这种独特的坏死形式在文献中被错误地赋予了多种名称,包括凝固性坏死和显微镜下坏死,根据上述大体和显微镜发现,这些名称并不合适。显然,这是一种特定类型的坏死,因此使用描述性术语“颗粒状坏死”来区分这种类型的坏死与其他类型。GN 的存在被认为发生在多种肿瘤类型中,在肾细胞癌中很常见,已经证明其具有独立的预后意义。在一些子宫的上皮和间质肿瘤中,GN 的存在也具有预后意义,并且是区分子宫平滑肌瘤和平滑肌肉瘤的特征性表现。GN 的发病机制尚未解决。它不显示细胞凋亡的特征,在最近的研究中已显示出与坏死性凋亡相关的一些分子变化。